Top

Published in:

01-09-2008 | Melanomas

How Well Are We Taking Care of Melanoma Patients in the USA?

Author: Vernon K. Sondak, MD

Published in: Annals of Surgical Oncology | Issue 9/2008

Excerpt

Increasingly, “compliance” with adopted standards of practice is becoming synonymous with the delivery of “quality” medical care to our patients. For our melanoma patients, the guidelines promulgated by the National Cancer Centers Networks (NCCN)1 are one such set of standards, and have been widely disseminated. But to what extent are we complying with the NCCN melanoma guidelines, and to what extent does compliance with them indicate that high-quality medical care is being delivered? Current and recent publications in Annals of Surgical Oncology shed light on these issues, but raise as many questions as they answer. …

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Melanoma 2008. Accessed at www.nccn.org

Erickson JL, Velasco JM, Hieken TJ. Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables. Ann Surg Oncol 2008; 15:1211–7PubMedCrossRef

Foster JE, Velasco JM, Hieken TJ. Adverse outcomes associated with non-compliance with melanoma treatment guidelines. Ann Surg Oncol 2008; DOI: 10.1245/s10434-008-0021-0 [ASO-2008-03-0221]

Bilimoria KY, Balch CM, Bentrem, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 2008; 15(6):1566–76 [ASo-2008-01-0011]PubMedCrossRef

Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel node biopsy. Surgery 2007; 141:728–35PubMedCrossRef

Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355:1307–17PubMedCrossRef

Thomas JM. Prognositic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 2008; 5:18–23PubMedCrossRef

Thomas JM, Hayes AJ. Sentinel lymph node biopsy in melanoma in 2008. PPO Updates 2008; 22:1–9

Thomas JM. Sentinel lymph node biopsy in malignant melanoma. Brit Med J 2008; 336:902–3

10.

Van Akkooi ACJ, de Wilt JHW, Verhoef C, et al. Isolated tumor cells and long-term prognosis of patients with melanoma. Ann Surg Oncol 2008; 15(5):1547–8PubMedCrossRef

11.

Eggermont AM, Suciu S, Santinami M, et al. EORTC 18991: Long-term adjuvant pegylated interferon-alpha2b (PEG-IFN) compared to observation in resected stage III melanoma, final results of a randomized phase III trial. J Clin Oncol 2007; 25:473s

12.

Anaya DA, Xing Y, Feng L, et al. Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients early stage III disease. Cancer 2008; 112:2030–7PubMedCrossRef

13.

Riker AI, Sondak VK. Complications of soft-tissue tumor surgery. In: Mulholland MW, Doherty GM, eds. Complications in surgery. Philadelphia, PA: Lippincott Williams & Wilkins, 2006, pp 619–27

14.

Sarnaik AA, Puleo CA, Sondak VK. Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma. Cancer Control J (in press)

Title: How Well Are We Taking Care of Melanoma Patients in the USA?
Author: Vernon K. Sondak, MD
Publication date: 01-09-2008
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 9/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-008-9997-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

How Well Are We Taking Care of Melanoma Patients in the USA?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2008

Do Micromorphometric Features of Metastatic Deposits Within Sentinel Nodes Predict Nonsentinel Lymph Node Involvement in Melanoma?

Getting to Better Cancer Care: Results of a Society of Surgical Oncology Survey

Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?

Sentinel Lymph Node Biopsy in Melanoma: Assessment of Risk

In Reply: Local Excision as an Optional Tool to Individualize Treatment of Rectal Cancer

Prognostic Relevance of Tensin4 Expression in Human Gastric Cancer